ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1565

Depression and Fatigue in Patients with Ankylosing Spondylitis

Ji Hui Shin1, Sun Ju Ahn2 and Tae-Hwan Kim3, 1rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Medical Research Coordinator, Hanyang Univerity Hospital for Rheumatic Disease Research Center, Seoul, Korea, Republic of (South), 3Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ankylosing spondylitis (AS), depression and fatigue, Disease Activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: ARHP Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Ankylosing spondylitis (AS) is a chronic inflammatory disease that leads to bony ankyloses. The disease occurs in early adulthood, a critical stage in life, causing physical and mental problems. There are many researches on the degrees of ankyloses and activity of the disease, but studies correlating AS with psychological effects—such as depression and fatigue—are rarer. Therefore, we sought to identify depression status in patients with AS and to find correlations among depression, fatigue, and disease activity.

Methods: The subjects of the study were 300 patients with AS, whose data were collected in the hospital from March 2017 to April 2017. All subjects agreed to participate in the research. The data were collected based on the self-reported survey that inquires general features (sex, age, and disease period) and the level of depression measured by CES-D. Based on the CES-D score, the patients were grouped depending on depression level (0-15: normal, 16-21: moderate, 22 : severe). Depression levels were compared to the disease activity measured by BASDAI, BASFI, ESR, CRP and fatigue level, measured by FACIT-F. The collected data were statistically analyzed utilizing SPSS statistics 24.0.

Results: 82.7 % of the patients were male, and average age and disease duration were 37.9 years old and 7.21 years. 21 percent of the patients reported smoking, and 55 % drinking. 3.3 % were diagnosed with depression, with a BASDAI of 3.35 and BASFI of 1.72. ESR and CRP were 19.02 mm/hr and 1.25 mg/dl each. The average of CES-D, or level of depression, was 11.12, which is normal, but 22.1 % of the patients had a moderate depression level. The degree of depression correlated with BASDAI, BASFI, and FACIT-F, but it was unrelated with disease duration. The fatigue level was 15.5, which is normal, and was less than the degree of depression. Fatigue showed a correlation with depression and disease activity. Depression was shown to be correlated with diseases activity (BASDAI, BASFI), but fatigue was not.

Conclusion:

22 % of the patients with AS showed a moderate level of depression, which need intensive treatment. Depression levels correlated with disease activity, but it was unrelated with disease period. It seems that the aftereffects of AS continue after the onset of the disease. This study may contribute to reducing disease activity and improving AS patients’ quality of life by regulating depression and fatigue.


Disclosure: J. H. Shin, None; S. J. Ahn, None; T. H. Kim, None.

To cite this abstract in AMA style:

Shin JH, Ahn SJ, Kim TH. Depression and Fatigue in Patients with Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/depression-and-fatigue-in-patients-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-and-fatigue-in-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology